Diabetes mellitus worsens antioxidant status in patients with chronic pancreatitis

American Journal of Clinical Nutrition

Volumn 81, Issue 5, 2005, Pages 1117-1125

  Quilliot, Didier ^a,b   Walters, Evelyne ^d   Bonte, Jean Paul ^c   Fruchart, Jean Charles ^d   Duriez, Patrick ^d   Ziegler, Olivier ^a  

^a Ctr Hospitalier Univ de Nancy   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c UNIV LILLE   (France)

^d INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Antioxidant; Chronic pancreatitis; Diabetes mellitus; Immune complexes; Malondialdehyde; Oxidized LDL

Indexed keywords

ALPHA TOCOPHEROL; CAROTENOID; CATALASE; COPPER; GLUCOSE; RETINOL; SELENIUM; ZINC; ANTIOXIDANT; ASCORBIC ACID;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; COPPER BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HEALTH STATUS; HUMAN; LIPID OXIDATION; MALE; MINERAL BLOOD LEVEL; OXIDATIVE STRESS; VITAMIN BLOOD LEVEL; ZINC BLOOD LEVEL; BLOOD; BODY MASS; CASE CONTROL STUDY; CHRONIC DISEASE; METABOLISM; MIDDLE AGED; PANCREATITIS;

ADULT; ANTIOXIDANTS; ASCORBIC ACID; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHRONIC DISEASE; DIABETES MELLITUS; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PANCREATITIS; SELENIUM; VITAMIN A; VITAMIN E; ZINC;

EID: 20544475042     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/81.5.1117     Document Type: Article

References (67)

1. Dutta SK, Bustin MP, Russell RM, Costa BS. Deficiency of fat-soluble vitamins in treated patients with pancreatic insufficiency. Ann Intern Med 1982;97:549-52.
2. Marotta F, Labadarios D, Frazer L, Girdwood A, Marks IN. Fat-soluble vitamin concentration in chronic alcohol-induced pancreatitis. Relationship with steatorrhea. Dig Dis Sci 1994;39:993-8.
3. Funakoshi A, Kimura T, Shinozaki H, Ibayashi H. Comparisons between absorption of vitamin E in patients with chronic pancreatitis and healthy controls: the bioavailability of vitamin E. Tohoku J Exp Med 1986;148:393-401.
4. Thompson GR, Lewis B, Booth CC. Absorption of vitamin D3-3H in control subjects and patients with intestinal malabsorption. J Clin Invest 1966;45:94-102.
5. Yokota T, Tsuchiya K, Tsukagoshi H, Miyakawa H, Hasumura Y. Vitamin E deficiency in acquired fat malabsorption. J Neurol 1990;237:103-6.
6. Van Gossum A, Closset P, Noel E, Cremer M, Neve J. Deficiency in antioxidant factors in patients with alcohol-related chronic pancreatitis. Dig Dis Sci 1996;41:1225-31.
7. Kelleher J. Nutritional status in chronic pancreatic steatorrhoea. In: Mitchell CJ, Kelleher J, eds. Pancreatic disease in clinical practice. London: Pitman, 1981:257-66.
8. Quilliot D, Dousset B, Guerci B, Dubois F, Drouin P, Ziegler O. Evidence that diabetes mellitus favors impaired metabolism of zinc, copper, and selenium in chronic pancreatitis. Pancreas 2001;22:299-306.
9. Yadav S, Day JP, Mohan V, Snehalatha C, Braganza JM. Selenium and diabetes in the tropics. Pancreas 1991;6:528-33.
10. Guice KS, Miller DE, Oldham KT, Townsend CM, Thompson JC. Superoxide dismutase and catalase: a possible role in establishing pancreatitis. Am J Surg 1986;151:163-9.
11. Wisner J, Green D, Ferrell L, Renner I. Evidence for a role of oxygen derived free radicals in the pathogenesis of caerulein induced acute pancreatitis in rats. Gut 1988;29:1516-23.
12. Braganza JM, Jeffrey IJM, Foster J, Mccloy RF. Recalcitrant pancreatitis: eventual control by antioxidants. Pancreas 1987;2:489-94.
13. Steinberg D, Witztum JL. Lipoproteins and atherogenesis. Current concepts. JAMA 1990;264:3047-52.
14. Schoenberg MH, Birk D, Beger HG. Oxidative stress in acute and chronic pancreatitis. Am J Clin Nutr 1995;62(suppl):1306S-14S.
15. Ziegler O, Candiloros H, Guerci B, Got I, Crea T, Drouin P. Lower-extremity arterial disease in diabetes mellitus due to chronic pancreatitis. Diabetes Metab 1994;20:540-5.
16. Sjoberg RJ, Kidd GS. Pancreatic diabetes mellitus. Diabetes Care 1989;12:715-24.
17. Verus AP, Samman S. Urinary zinc as a marker of zinc intake: results of a supplementation trial in free-living men. Eur J Clin Nutr 1994;48:219-21.
18. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol 1992;13:341-90.
19. Acheson DW, Rose P, Houston JB, Braganza JM. Induction of cytochromes P-450 in pancreatic disease: consequence, coincidence or cause? Clin Chim Acta 1985;153:73-84.
20. Quilliot D, Walters E, Böhme P, et al. Fatty acid abnormalities in chronic pancreatitis: effect of concomitant diabetes mellitus. Eur J Clin Nutr 2003;57:496-503.
21. Beaumont JL, Doucet F, Vivier P, Antonucci M. Immunoglobulin-bound lipoproteins (Ig-Lp) as markers of familial hypercholesterolemia, xanthomatosis and atherosclerosis. Atherosclerosis 1988;74:191-201.
22. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991;40:405-12.
23. Semenkovich CF, Heinecke JW. The mystery of diabetes and atherosclerosis. Diabetes 1997;46:327-34.
24. Schwartz CJ, Valente AJ, Kelley JL, Cayatte AJ, Rozek MM. Pathogenesis of the atherosclerotic lesion. Implications for diabetes mellitus. Diabetes Care 1992;15:1156-67.
25. Som S, Basu S, Mukherjee D. Ascorbic acid metabolism in diabetes mellitus. Metabolism 1981;30:572-7.
26. Jennings PE, Chirico S, Jones AF, Lunec J, Barnett AH. Vitamin C metabolites and microangiopathy in diabetes mellitus. Diabetes Res 1987;6:151-4.
27. Stankova L, Riddle M, Larned J, et al. Plasma ascorbate concentrations and blood cell dehydroascorbate transport in patients with diabetes mellitus. Metabolism 1984;33:347-53.
28. Cunningham JJ, Ellis SL, McVeigh KL, Levine RE, Calles-Escandon J. Reduced mononuclear leucocyte ascorbic acid content in adults with insulin-dependent diabetes mellitus consuming adequate dietary vitamin C. Metabolism 1991;40:146-9.
29. Karpen CW, Cataland S, O'Dorisio TM, Panganamala RV. Production of 12-hydroxyeicosatetranoic acid and vitamin E status in platelets from type 1 human diabetic subjects. Diabetes 1985;34:526-31.
30. Karpen CW, Cataland S, O'Dorisio TM, Panganamala RV. Interrelation of platelet vitamin E and thromboxane synthesis in type 1 diabetes mellitus. Diabetes 1984;33:239-43.
31. McNair P, Kiilerich S, Christiansen C. Hyperzincuria in insulin treated diabetes mellitus: its relation to glucose homeostasis and insulin administration. Clin Chim Acta 1981;112:343-8.
32. Martin Mateo MC, Bustamante JB, Cantalapiedra MAG. Serum zinc, copper and insulin in diabetes mellitus. Biomedecine 1978;29:56-8.
33. Collier A, Wilson R, Bradley H, Thomson JA, Small M. Free radical activity in Type 2 diabetes. Diabetic Med 1990;7:27-30.
34. World Health Organization. Diabetes mellitus: report of a WHO study group. World Health Organ Tech Rep Ser 1985;727:9-17.
35. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20:1183-97.
36. Van de Kamer JH, Bockel H, Weijers HA. Rapid method for the determination of fat in feces. J Biol Chem 1949;177:347-55.
37. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
38. Folch H, Less M, Sloane-Stanley GH. A simple method for isolation and purification of total lipids from animal tissues. J Biol Chem 1957;226:497-509.
39. Boullier A, Hamon M, Walters-Laporte E, et al. Detection of autoantibodies against oxidized low-density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery disease. Clin Chim Acta 1995;238:1-10.
40. Steghens JP, Lyan B, Le Moel G, et al. Measurement of carotenoids by high pressure liquid chromatography: from difficulties to solutions. Ann Biol Clin 2000;58:327-35.
41. Teissier E, Walters-Laporte E, Duhem C, Luc G, Fruchart JC, Duriez P. Rapid quantification of alpha-tocopherol in plasma and low- and high-density lipoproteins. Clin Chem 1996;42:430-5.
42. Arnaud J, Chappuis P, Clavel JP, Bienvenu F, Favier A. Methods of determination of selenium in biological matter. Ann Biol Clin 1986;44:459-69.
43. L'Abbe MR, Fisher PWJ. An automated method for the determination of cu-zn superoxide dismutase in plasma and erythrocytes using an AbA-200 direct analyser. Clin Biochem 1986;19:175-8.
44. Gunzler WA, Kremzers H, Flohe L. An improved coupled test for glutathione peroxidase in blood. Z Klin Chem Klin Biochem 1974;12:444-8.
45. Beers R, Sizer W. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 1952;195:133-40.
46. Jessup W, Rankin SM, De Walley CV, Hoult JRS, Scott J, Leake DS. Alpha-tocopherol consumption during low-density lipoprotein oxidation. Biochem J 1990;265:399-405.
47. Esterbauer H, Dieber-Rotheneder M, Striegl G, Waeg G. Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am J Clin Nutr 1991;53(suppl):314S-21S.
48. Kleinveld HA, Hak-Lemmers HL, Stalenhoef AF, Demacker PN. Improved measurement of low-density-lipoprotein susceptibility to copper-induced oxidation: application of a short procedure for isolating low-density lipoprotein. Chem Clin 1992;38:2066-72.
49. Babiy AV, Gebicki JM, Sullivan DR. Vitamin E content and low density lipoprotein oxidizability induced by free radicals. Atherosclerosis 1990;81:175-82.
50. Winklhofer-Roob BM, Ziouzenkova O, Puhl H, et al. Impaired resistance to oxidation of low density lipoprotein in cystic fibrosis: improvement during vitamin E supplementation. Free Radic Biol Med 1995;19:725-33.
51. Suzumura K, Tanaka K, Yasuhara M, Narita H. Inhibitory effects of fluvastatin and its metabolites on hydrogen peroxide-induced oxidative destruction of hemin and low-density lipoprotein. Biol Pharm Bull 2000;23:873-8.
52. Rikitake Y, Kawashima S, Takeshita S, et al. Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits. Atherosclerosis 2001;154:87-96.
53. Reaven P, Parthasarathy S, Grasse BJ, Miller E, Steinberg D, Witztum JL. Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects. J Clin Invest 1993;91:668-76.
54. Faure P, Benhamou PY, Petard A, Halimi S, Roussel AM. Lipid peroxidation in insulin-dependent diabetic patients with early retina degenerative lesions: effects of an oral zinc supplementation. Eur J Clin Nutr 1995;49:282-8.
55. Nath N, Chari N, Rathi B. Superoxide dismutase in diabetic polymorphonuclear in diabetic polymorphonuclear leucocytes. Diabetes 1984;33:586-9.
56. Akkus I, Kalak S, Vural H, et al. Leukocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase and serum and leukocyte vitamin C levels of patients with type II diabetes mellitus. Chim Acta 1996;244:221-7.
57. Hartnett ME, Stratton RD, Browne RW, Rosner BA, Lanham RJ, Armstrong D. Serum markers of oxidative stress and severity of diabetic retinopathy. Diabetes Care 2000;23:234-40.
58. Heales SJ. Catalase deficiency, diabetes, and mitochondrial function. Lancet 2001;357:314-314 (letter).
59. Ruiz C, Alegria A, Barbera R, Farre R, Lagarda MJ. Lipid peroxidation and antioxidant enzyme activities in patients with type 1 diabetes mellitus. Scand J Clin Lab Invest 1999;59:99-105.
60. Palinski W, Rosenfeld ME, Yla-Herttuala S, et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A 1989;86:1372-6.
61. Salonen JT, Yla-Herttuala S, Yamamoto R, et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992;339:883-7.
62. Armstrong VW, Wieland E, Diedrich F, et al. Serum antibodies to oxidised low-density lipoprotein in pre-eclampsia and coronary heart disease. Lancet 1994;343:1570-6.
63. Virella G, Virella I, Leman RB, Pryor MB, Lopes-Virella MF. Antioxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers. Int J Clin Lab Res 1993;23:95-101.
64. Festa A, Kopp HP, Schernthaner G, Menzel EJ. Autoantibodies to oxidised low density lipoproteins in IDDM are inversely related to metabolic control and microvascular complications. Diabetologia 1998;41:350-6.
65. Nakamura T, Takebe K, Yamada N, et al. Bile acid malabsoption as a cause of hypocholesterolemia seen in patients with chronic pancreatitis. Int J Pancreatol 1994;16:165-9.
66. Wakasugi H, Nakayama K, Abe M, Hara Y, Ibayashi H. Studies on intestinal malabsorption in chronic pancreatitis. Gastroenterol Jpn 1976;11:374-9.
67. Vuoristo M, Väänänen H, Miettinen TA. Cholesterol malabsorption in pancreatic insufficiency: effects of enzyme substitution. Gastroenterology 1992;102:647-55.